2022-06-02Zeitschriftenartikel
SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022
dc.contributor.author | Sievers, Claudia | |
dc.contributor.author | Zacher, Benedikt | |
dc.contributor.author | Ullrich, Alexander | |
dc.contributor.author | Huska, Matthew | |
dc.contributor.author | Fuchs, Stephan | |
dc.contributor.author | Buda, Silke | |
dc.contributor.author | Haas, Walter | |
dc.contributor.author | Diercke, Michaela | |
dc.contributor.author | an der Heiden, Matthias | |
dc.contributor.author | Kröger, Stefan | |
dc.date.accessioned | 2022-07-19T10:22:21Z | |
dc.date.available | 2022-07-19T10:22:21Z | |
dc.date.issued | 2022-06-02 | none |
dc.identifier.other | 10.2807/1560-7917.ES.2022.27.22.2200396 | |
dc.identifier.uri | http://edoc.rki.de/176904/9956 | |
dc.description.abstract | German national surveillance data analysis shows that hospitalisation odds associated with Omicron lineage BA.1 or BA.2 infections are up to 80% lower than with Delta infection, primarily in ≥ 35-year-olds. Hospitalised vaccinated Omicron cases’ proportions (2.3% for both lineages) seemed lower than those of the unvaccinated (4.4% for both lineages). Independent of vaccination status, the hospitalisation frequency among cases with Delta seemed nearly threefold higher (8.3%) than with Omicron (3.0% for both lineages), suggesting that Omicron inherently causes less severe disease. | eng |
dc.language.iso | eng | none |
dc.publisher | Robert Koch-Institut | |
dc.rights | (CC BY 3.0 DE) Namensnennung 3.0 Deutschland | ger |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/de/ | |
dc.subject.ddc | 610 Medizin und Gesundheit | none |
dc.title | SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022 | none |
dc.type | article | |
dc.identifier.urn | urn:nbn:de:0257-176904/9956-5 | |
dc.type.version | publishedVersion | none |
local.edoc.container-title | Eurosurveillance | none |
local.edoc.container-issn | 1560-7917 | none |
local.edoc.type-name | Zeitschriftenartikel | |
local.edoc.container-type | periodical | |
local.edoc.container-type-name | Zeitschrift | |
local.edoc.container-url | https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.22.2200396#html_fulltext | none |
local.edoc.container-publisher-name | European Centre for Disease Prevention and Control | none |
local.edoc.container-volume | 27 | none |
local.edoc.container-issue | 22 | none |
local.edoc.container-year | 2022 | none |
dc.description.version | Peer Reviewed | none |